Kim Iversen and Robby Soave, discuss the future of COVID ‘miracle drug’ molnupiravir in response to News that Merck has requested emergency use authorization from the FDA.
Rising is a weekday morning show with bipartisan hosts that breaks the mold of morning TV by taking viewers inside the halls of Washington power like never before. The show leans into the day’s political cycle with cutting edge analysis from DC insiders who can predict what is going to happen. It also sets the day’s political agenda by breaking exclusive News with a team of scoop-driven reporters and demanding answers during interviews with the country’s most important political newsmakers.
Follow Rising on social media: